202 related articles for article (PubMed ID: 11569696)
1. Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.
Markowitz JE; Brown KA; Mamula P; Drott HR; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2001 Sep; 96(9):2688-90. PubMed ID: 11569696
[TBL] [Abstract][Full Text] [Related]
2. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease.
Pascarella F; Martinelli M; Miele E; Del Pezzo M; Roscetto E; Staiano A
J Pediatr; 2009 Jun; 154(6):854-8. PubMed ID: 19230908
[TBL] [Abstract][Full Text] [Related]
3. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
Chan EL; Seales D; Drum H
Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
6. [Six years evaluation of Clostridium difficile associated diarrhea].
Ercis S; Ergin A; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
Fille M; Larcher C; Dierich MP; Allerberger F
Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
[TBL] [Abstract][Full Text] [Related]
9. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
11. Is Clostridium difficile a pathogen in the newborn intensive care unit? A prospective evaluation.
Enad D; Meislich D; Brodsky NL; Hurt H
J Perinatol; 1997; 17(5):355-9. PubMed ID: 9373839
[TBL] [Abstract][Full Text] [Related]
12. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories.
Fitzpatrick F; Oza A; Gilleece A; O'Byrne AM; Drudy D;
J Hosp Infect; 2008 Apr; 68(4):315-21. PubMed ID: 18353502
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.
Könönen E; Rasinperä M; Virolainen A; Mentula S; Lyytikäinen O
Anaerobe; 2009 Dec; 15(6):261-5. PubMed ID: 19591954
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory-based evaluation of TOX A/B QUIK CHEK "NISSUI" to detect toxins A and B of clostridium difficile].
Nakasone I; Shiohira CM; Yamane N
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2007; 18(2):109-16. PubMed ID: 18154439
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Clostridium difficile-associated intestinal disease.
Rolfe RD
Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
[TBL] [Abstract][Full Text] [Related]
19. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
Sednaoui P; el Mantih B; Cauwell M
Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
[TBL] [Abstract][Full Text] [Related]
20. Impact of Clostridium difficile on inflammatory bowel disease.
Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
